Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind, Randomised, Parallel Group, Placebo Controlled Clinical Trial of S(+)-Ibuprofen Effects on TxB2 Concentrations and Platelet Aggregation in Aspirin-treated Healthy Adult Volunteers

NCT00442585 is registered in ClinicalTrials.gov with Gebro Pharma GmbH as lead sponsor.

NCT NCT00442585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind, Randomised, Parallel Group, Placebo Controlled Clinical Trial of S(+)-Ibuprofen Effects on TxB2 Concentrations and Platelet Aggregation in Aspirin-treated Healthy Adult Volunteers
Lead sponsor
Gebro Pharma GmbH
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2006
Completion date
October 31, 2007
Enrollment
72
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug interactions